14M130: How Do We Use Rheumatology Medications with Limited Safety Data During Pregnancy?

Monday, November 14, 2022

12:00 PM – 1:00 PM Eastern Time

Location: Room 113

CE: 1

All of the relevant financial relationships listed for faculty have been mitigated.

Moderator(s)

LS

Lisa Sammaritano, MD

Hospital for Special Surgery
Scarsdale, NY, United States

Disclosure(s): No financial relationships with ineligible companies to disclose

This session will address the common yet challenging clinical scenario of recommending therapy during pregnancy for the patient with rheumatic disease with limited treatment options. Participants will hear the latest updates from ongoing pregnancy registries and how data from these registries may help in counseling patients. Using a case-based approach, participants will also review the available safety data for rheumatic medications and learn how to incorporate these data into patient counseling using shared decision-making.

Learning Objectives:

Describe the role of pregnancy registries and use of this data to inform medication counseling and treatment decisions for autoimmune diseases in pregnancy
Using a case-based approach, identify the safety of rheumatic medications during pregnancy for which limited data have been available
Apply shared decision-making counseling techniques to optimize medication management during pregnancy

Presentations:

12:00 PM – 12:20 PM Eastern Time

Using Registry Data to Inform Treatment Decisions in Pregnancy
Speaker: Christina D. Chambers, PhD, MPH – University of California, San Diego
12:20 PM – 12:40 PM Eastern Time

Case-Based Approaches for Shared Decision-Making in Selecting Treatments in Pregnancy
Speaker: Megan E. Clowse, MD, MPH – Duke University
12:40 PM – 1:00 PM Eastern Time

Q&A